Department of Health and Human Services Transparency and Fairness in Civil Administrative Enforcement Actions, 3010-3015 [2021-00592]
Download as PDF
3010
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Rules and Regulations
described in paragraph (a)(1) of this
section.
(b) End of the period. The MCIT
pathway for a breakthrough device ends
as follows:
(1) No later than 4 years from the date
the breakthrough device received FDA
market authorization.
(2) Prior to 4 years if a manufacturer
withdraws the breakthrough device
from the MCIT pathway.
(3) Prior to 4 years if the breakthrough
device becomes the subject of a national
coverage determination or otherwise
becomes noncovered through law,
regulation, or at the discretion of the
Secretary subsequent to an FDA medical
device safety communication or
Warning Letter.
(4) Prior to 4 years if the FDA removes
authorization of a device, the
breakthrough device is removed from
the MCIT pathway.
Dated: December 31, 2020.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
Dated: January 5, 2021.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2021–00707 Filed 1–12–21; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
45 CFR Part 1
[HHS–OS–2021–0001]
RIN 0991–AC18
Department of Health and Human
Services Transparency and Fairness in
Civil Administrative Enforcement
Actions
Office of the Secretary,
Department of Health and Human
Services.
ACTION: Final rule.
AGENCY:
The Department of Health and
Human Services is issuing regulations
promoting transparency and fairness in
civil enforcement actions. These
regulations will help to ensure that
regulated parties receive fair notice of
laws and regulations they are subject to,
and have an opportunity to contest an
agency determination prior to the
agency taking an action that has a legal
consequence.
DATES: Effective January 12, 2021.
FOR FURTHER INFORMATION CONTACT:
Brenna Jenny, Department of Health and
Human Services, 200 Independence
khammond on DSKJM1Z7X2PROD with RULES
SUMMARY:
VerDate Sep<11>2014
18:22 Jan 13, 2021
Jkt 253001
Avenue SW, Room 713F, Washington,
DC 20201. Email: Good.Guidance@
hhs.gov. Telephone: (202) 690–7741.
I. Statutory and Regulatory Background
The primary legal authority
supporting this rulemaking is 5 U.S.C.
301. That provision provides that the
‘‘head of an Executive department or
military department may prescribe
regulations for the government of his
department, the conduct of its
employees, the distribution and
performance of its business, and the
custody, use, and preservation of its
records, papers, and property.’’ This
statute authorizes an ‘‘agency to regulate
its own affairs,’’ and issue rules, such as
this one, that are ‘‘rules of agency
organization[,] procedure or practice.’’
Chrysler Corp. v. Brown, 441 U.S. 281,
309–10 (1979). Similarly, 42 U.S.C. 1302
provides that the Secretary ‘‘shall make
and publish such rules and regulations,
not inconsistent with this chapter, as
may be necessary to the efficient
administration of the functions with
which [he] is charged’’ under Chapter 7
of the Social Security Act. Chapter 7
contains, among other things, statutory
provisions governing Medicare,
Medicaid, and the Health Insurance
Portability and Accountability Act
(HIPAA).
The Administrative Procedure Act
(‘‘APA’’), 5 U.S.C. 551 et seq., specifies
the process by which such regulations
are promulgated. Department heads
generally must prescribe regulations
through notice-and-comment
rulemaking, but there is an exception for
‘‘rules of agency organization,
procedure, or practice.’’ The
requirements for notice and comment
prior to finalization also do not apply to
regulations that involve ‘‘a matter
relating to agency management or
personnel.’’ 5 U.S.C. 553(a)(2).
Because this final rule only specifies
procedures that agency personnel must
follow or that will govern civil
enforcement actions, it is exempt from
the requirement for notice and comment
prior to finalization. In determining
whether notice-and-comment
rulemaking is required, the ‘‘critical
feature is that [the rule] covers agency
actions that do not themselves alter the
rights or interests of the parties,
although it may alter the manner in
which the parties present themselves or
their viewpoints to the agency.’’ Nat’l
Sec. Counselors v. CIA, 931 F. Supp. 2d
77, 106–07 (D.D.C. 2013) (quoting
Batterton v. Marshall, 648 F.2d 694, 707
(D.C. Cir. 1980)). This rule is exempt
from notice and comment because it
does not ‘‘put[ ] a stamp of approval or
disapproval on a given type of
PO 00000
Frm 00058
Fmt 4700
Sfmt 4700
behavior.’’ Am. Hosp. Assoc. v. Bowen,
834 F.2d 1037, 1047 (D.C. Cir. 1987).
What had been a regulatory violation
prior to finalization of this rule still is;
the Department of Health and Human
Services (‘‘HHS’’ or ‘‘the Department’’)
is only modifying the procedures
governing civil enforcement actions and
the Department’s civil enforcement
action practices. To be sure, these
procedural modifications, like most
rules of agency procedure or personnel,
might have some impact on the public.
But agency rules that impose
‘‘derivative,’’ ‘‘incidental,’’ or
‘‘mechanical’’ burdens upon regulated
individuals are considered procedural,
rather than substantive, and are
therefore exempt from the notice-andcomment requirement. Id. at 1051.
Moreover, to the extent this rule has
effects on the public, it only provides
additional protections to the public,
rather than depriving the public of any
rights or interests it previously had.
The APA requires that
‘‘administrative policies affecting
individual rights and obligations be
promulgated pursuant to certain stated
procedures so as to avoid the inherently
arbitrary nature of unpublished ad hoc
determinations.’’ Morton v. Ruiz, 415
U.S. 199, 232 (1974). The Freedom of
Information Act amended the APA to
advance this goal, and generally
requires that agencies publish in the
Federal Register their substantive rules
of general applicability, statements of
general policy, and interpretations of
law that are generally applicable. 5
U.S.C. 552(a)(1)(D). Unless a party has
actual and timely notice of the terms of
a rule or policy, the Freedom of
Information Act generally provides that
a party may not be adversely affected by
a rule or policy required to be published
in the Federal Register that is not so
published. 5 U.S.C. 552(a)(1)(flush
language). This rule of agency procedure
ensures that HHS actions comport with
these requirements.
II. Summary of Transparency and
Fairness Regulations
To provide regulated parties with
greater transparency and fairness in
administrative actions, and consistent
with the requirements of Executive
Order 13892 of October 9, 2019,
‘‘Promoting the Rule of Law Through
Transparency and Fairness in Civil
Administrative Enforcement and
Adjudication,’’ 84 FR 55239 (Oct. 15,
2019), HHS is setting forth policies that
promote transparency and fairness in
civil enforcement actions that will apply
to all divisions of HHS. The
requirements in this rule amend 45 CFR
part 1.
E:\FR\FM\14JAR1.SGM
14JAR1
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Rules and Regulations
This rule is one component of the
Department’s broader regulatory reform
initiative. The rule is designed to ensure
accountability, fairness of how the
Department uses guidance, proper use
of guidance documents, and
opportunities for third parties to be
heard, and to safeguard the important
principles underlying the United States
administrative law system.
khammond on DSKJM1Z7X2PROD with RULES
A. Scope (45 CFR 1.1)
The requirements established
pursuant to this rule in §§ 1.2(b) and 1.6
through 1.9 apply to civil enforcement
actions by any component of the
Department. Sections 1.3 through 1.5 (as
well as the definitions in § 1.2 that were
added through the Good Guidance
Practices final rule at 85 FR 78770 (Dec.
7, 2020), and that we will recodify in
this rule at § 1.2(a)) will continue to
apply to all guidance documents until
FDA amends its good guidance practices
regulation to be consistent with the HHS
Good Guidance Practices rule, at which
point §§ 1.2(a) and 1.3 through 1.5 shall
apply to all divisions of HHS except
FDA.
Nothing in this rule shall apply:
• To any action that pertains to
foreign or military affairs, or to a
national security or homeland security
function of the United States (other than
procurement actions and actions
involving the import or export of
nondefense articles and services);
• To any action related to a criminal
investigation or prosecution, including
undercover operations, or any civil
enforcement action or related
investigation by the Department of
Justice, including any action related to
a civil investigative demand under 18
U.S.C. 1968;
• To any action related to detention,
seizure, or destruction of counterfeit
goods, pirated goods, or other goods that
infringe intellectual property rights;
• To any investigation of misconduct
by an agency employee or any
disciplinary, corrective, or employment
action taken against an agency
employee; or
• In any other circumstance or
proceeding to which application of this
order, or any part of this order, would,
in the judgment of the Secretary of HHS,
undermine the national security.
B. Definitions (45 CFR 1.2)
The definitions section at 45 CFR 1.2
is amended to include the following
definitions at paragraph (b).
Civil Enforcement Action
HHS defines ‘‘civil enforcement
action’’ to mean an action with legal
consequence taken by the Department
VerDate Sep<11>2014
18:22 Jan 13, 2021
Jkt 253001
based on an alleged violation of the law.
Such actions include administrative
enforcement proceedings and
enforcement adjudication (which is the
administrative process undertaken by
any component of the Department to
resolve the legal rights and obligations
of specific parties with regard to a
particular enforcement issue pending
before it) but do not include actions
taken in the normal course of the
Department’s regulatory
communications or decision-making, for
example, decisions on product
applications (such as approvals or
denials/withdrawals of approval),
claims authorizations, responses to
citizen petitions, food or color additive
petitions, or public health notifications.
Legal Consequence
HHS defines ‘‘legal consequence’’ as
the result of an action that directly or
indirectly affects substantive legal rights
or obligations including by subjecting a
regulated party to potential liability in
an enforcement action. The meaning of
this term is informed by the Supreme
Court’s discussion in U.S. Army Corps
of Engineers v. Hawkes Co., 136 S. Ct.
1807, 1813–16 (2016), and includes, for
example, agency letters or orders
establishing or increasing the
probability of liability for regulated
parties in a subsequent enforcement
action, Ipsen Biopharmaceuticals, Inc.
v. Azar, 943 F.3d 953, 956 (D.C. Cir.
2019); Rhea Lana, Inc. v. Dep’t of Labor,
824 F.3d 1023, 1030 (D.C. Cir. 2016). It
does not include a warning letter or
other communication, such as one
describing inspectional observations,
that pursuant to agency policy is
intended to provide notice to a
regulated party and elicit voluntary
compliance. Such warning letters and
inspectional observations have no
immediate regulatory implications for
the entity, are an interim step in the
agency’s compliance communications
with an entity, and are not final agency
action that has legal consequences for a
party. See Orton Motor, Inc. v. HHS, 884
F.3d 1205, 1215 (D.C. Cir. 2018);
Holistic Candlers & Consumers Ass’n v.
FDA, 664 F.3d 940 (D.C. Cir. 2012); see
also Hi-Tech Pharm., Inc. v. Hahn, Civ.
No. 19–1268(RBW), 2020 WL 3498588,
*5 (D.D.C. June 29, 2020); Lystn, LLC v.
FDA, No. 19–cv–1943–PAB–KLM, 2020
WL 248962, *5 (D. Colo. Jan. 16, 2020);
Cody Labs., Inc. v. Sebelius, No. 10–CV–
00147–ABJ, 2010 WL 3119279, *11 (D.
Wyo. July 26, 2010), aff’d, 446 F. App’x
964, 969 (10th Cir. 2011); Gomperts v.
Azar, No. 1:19–cv–00345–DCN, 2020
WL 3963864, *4–5 (D. Idaho July 13,
2020).
PO 00000
Frm 00059
Fmt 4700
Sfmt 4700
3011
Unfair Surprise
HHS defines ‘‘unfair surprise’’ to
mean a lack of reasonable certainty or
fair warning, from the perspective of a
reasonably prudent member of regulated
industry, of what a legal standard
administered by an agency requires, or
the initiation of litigation by HHS
following ‘‘a very lengthy period of
conspicuous inaction,’’ in other words
deliberate inaction, suggesting the
agency previously had a different
interpretation. Christopher v.
SmithKline Beecham Corp., 567 U.S.
142, 156 (2012). However, an agency
does not create unfair surprise when it
proceeds with a new interpretation that
it established in notice-and-comment
rulemaking. See Martin v. Occupational
Safety & Health Review Comm’n, 499
U.S. 144, 158 (1991) (identifying
‘‘adequacy of notice to regulated
parties’’ as one factor relevant to the
reasonableness of the agency’s
interpretation).
The definitions currently at 45 CFR
1.2 will be moved into a new paragraph
(a). All definitions at paragraph (a)
apply to all components of HHS until
FDA amends its good guidance practices
regulation, at which point the
definitions at 45 CFR 1.2(a) shall apply
to all divisions of HHS except FDA. The
definitions at § 1.2(b) will apply to all
components of the Department,
including FDA.
C. Proper Department Reliance on
Guidance Documents (45 CFR 1.6)
This rule reiterates the application of
certain existing legal principles to
HHS’s use of guidance documents:
When the Department takes a civil
enforcement action or otherwise makes
a determination based on an alleged
violation of law that has legal
consequence for a person or state, it
must allege or establish the violation of
law by applying statutes or regulations.
HHS may not use guidance documents
to impose binding requirements or
prohibitions on persons outside of the
executive branch except as authorized
by law or expressly incorporated into a
contract. Noncompliance with a
standard or practice that is not in a
statute or regulation and announced
solely in a guidance document may not
be treated as itself a violation of
applicable statutes or regulations, unless
expressly authorized by statute.
This rule also explains the
appropriate circumstances when the
Department may use a guidance
document in civil enforcement actions.
The Department may use a guidance
document to explain the legal
applicability of a statute or regulation
E:\FR\FM\14JAR1.SGM
14JAR1
3012
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Rules and Regulations
khammond on DSKJM1Z7X2PROD with RULES
with regard to prohibition of conduct,
but when it does so, HHS may only use
the guidance document to articulate the
Department’s understanding of how a
statute or regulation applies to
particular circumstances. Except when
referring to a guidance document for
historical facts, the Department may
reference a guidance document in a civil
enforcement action only if it has
notified the public of such document to
convey that understanding in advance.
The Department must notify the public
in advance of a guidance document
through publication in the Department’s
guidance repository (as described in
§ 1.4 and available at hhs.gov/guidance).
D. Fairness and Notice in Civil
Enforcement Actions and
Administrative Inspections (45 CFR 1.7)
This rule would require the
Department to only apply standards or
practices that have been publicly stated
in a manner that would not cause unfair
surprise when HHS takes a civil
enforcement action or otherwise makes
a determination based on an alleged
violation of law that has legal
consequence for a person or state,
unless a statutory exception applies.
See, e.g., 42 U.S.C. 1395hh(e). For
purposes of this regulation, the
Department would consider standards
or practices to be publicly stated if
available in paper publications or on the
internet.
HHS avoids unfair surprise not only
when it imposes penalties but also
whenever it adjudges past conduct to
have violated the law. For example, the
Department generally cannot
retroactively impose liability on a party
for conduct that violates a new agency
interpretation. But see 42 U.S.C.
1395hh(e). The Department also may
not alter its interpretation during an
adjudicative proceeding if doing so
would impose new liability on parties
who have acted in good faith on the
prior interpretation. SmithKline
Beecham, 567 U.S. at 156 & n.15.
Section 7 of Executive Order 13892
requires that each agency that conducts
civil administrative inspections must
publish a rule of agency procedure
governing such inspections, if such a
rule does not already exist. The
Department is adding a requirement at
45 CFR 1.7 that HHS shall only conduct
civil administrative inspections
according to published rules of agency
procedure. While the Administrative
Procedure Act exempts these
subsequently issued rules of agency
procedure themselves from notice-andcomment rulemaking, see 5 U.S.C.
553(b)(3)(A), each agency must make the
rules governing its civil administrative
VerDate Sep<11>2014
18:22 Jan 13, 2021
Jkt 253001
inspections, including audits, publicly
available and readily accessible, such as
by posting them on a website.
E. Fairness and Notice in Jurisdictional
Determinations (45 CFR 1.8)
The requirement for fairness and
notice also extends to jurisdictional
determinations. If the Department relies
on a decision previously issued by an
agency within the Department in an
agency adjudication (i.e., proceedings
before and decided by the agency),
administrative order, or agency
document to assert a new or expanded
claim of jurisdiction (e.g., a claim to
regulate a new subject matter or a new
basis for liability, or a relinquishment of
a claim of jurisdiction), the Department
must give fair notice by publishing the
initial decision in the Federal Register
or the Department’s guidance
repository. See 45 CFR 1.4. The
Department should not rely on the new
claim of jurisdiction to take a civil
enforcement action regarding conduct
that occurred before such publication. A
claim of jurisdiction is not ‘‘new or
expanded’’ simply because it involves a
new or novel set of facts so long as it
is based on an established principle of
general applicability.
If the Department intends to rely on
a document arising out of litigation
(other than a publicly published
opinion of an adjudicator) such as a
brief, a consent decree, or a settlement
agreement, to establish jurisdiction in
future civil enforcement actions
involving persons who were not parties
to the litigation, the Department must
also publish that document in the
Federal Register or on the Department’s
guidance repository. Alongside
publication of the document, the
Department must also provide an
explanation of the document’s
jurisdictional implications. Publication
of a document discussed in this
paragraph may either be in full or by
citation, if the document is publicly
available.
HHS is also proposing that if the
Department seeks judicial deference to
its interpretation of a document arising
out of litigation (other than a publicly
published opinion of an adjudicator) in
order to establish a new or expanded
claim of jurisdiction, HHS must, before
seeking judicial deference, publish the
document or a notice of availability in
the Federal Register or on the
Department’s guidance repository, along
with an explanation of the document’s
jurisdictional implications.
PO 00000
Frm 00060
Fmt 4700
Sfmt 4700
F. Opportunity To Contest Agency
Determinations (45 CFR 1.9)
Providing regulated parties with the
opportunity to be heard, including
through informal oral or written
communications, prior to the
Department taking any civil
enforcement action that has legal
consequence is critical to ensuring that
the Department operates with
transparency and fairness. This rule will
require that, before any component of
the Department takes any civil
enforcement action with respect to a
particular entity that has legal
consequence for that entity—including
by issuing to such a person a notice of
noncompliance or other similar notice
that has immediate regulatory
consequence or the immediate effect of
subjecting the person to potential
liability—the Department must afford
that person an opportunity to be heard,
either orally or in writing, as deemed
appropriate at the Department’s
election. The rule will require HHS to
provide the person with its proposed
legal and factual determinations and
then give the person a reasonable
amount of time to respond to those
determinations. The specific timeframe
shall be in the discretion of the agency
but must be long enough to provide a
meaningful opportunity to be heard.
Certain circumstances may warrant a
time period of 30 days, while other
circumstances may warrant a shorter
period, such as 15 days or fewer,
particularly where existing agency
procedures already offer a shorter
period in which to respond. Unless the
Department withdraws the action, the
Department must then respond in
writing to the regulated party and
articulate the final basis for the
Department’s action. This written
response may be issued
contemporaneous to the Department
taking the action with legal
consequence. We anticipate that
generally, existing HHS procedures will
already satisfy these standards, and
where they do, those existing
procedures will continue in effect
unchanged. This rulemaking is not
intended to preempt existing rules of
agency procedure that are already
consistent with this rule. Furthermore,
where the Department takes an action
based on a predicate finding that was
reached following notice, an
opportunity to be heard, and a written
response, for example, where the
Department revokes Medicare
enrollment based on a prior exclusion or
felony conviction, these procedural
requirements are considered to have
already been satisfied.
E:\FR\FM\14JAR1.SGM
14JAR1
khammond on DSKJM1Z7X2PROD with RULES
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Rules and Regulations
These procedures regarding fair notice
and an opportunity to respond would
not apply where the agency, in its
discretion, determines there is a serious
threat to health, safety, or similar
emergency, or where a statute
specifically authorizes proceedings that
are inconsistent with this section,
including proceedings without a prior
opportunity to be heard. Where such a
threat arises and a statute does not
specifically authorize proceedings
without a prior opportunity to be heard,
HHS would still provide an affected
entity with an opportunity to be heard
and a written response as soon as
practicable. In this context, a serious
threat means that, as reasonably
determined by the Department, there is
a non-negligible likelihood of the threat
materializing.
We anticipate that the exception from
§ 1.9 for actions taken in the context of
threats to health, safety, or similar
emergencies will apply broadly to
public health agencies acting in
furtherance of their missions. Actions
will be considered to fall into this
exception regardless of whether there is
a showing of actual, imminent risk or
harm, either to persons or animals. The
agency has sole discretion to determine
when an action falls into this exception.
An agency may invoke this exception
regardless of whether agency action is
taken reactively (e.g., to address an
unsafe item currently on the market) or
proactively (e.g., to enforce regulations
needed to protect public health prior to
actual exposure by the public to unsafe
items). Actions that fall into this
exception include, for example,
enforcing age restrictions or other
controls around access to certain
regulated products, enforcing
manufacturer recordkeeping or
reporting requirements, enforcing
premarket requirements where there is
an absence of or insufficient data
concerning the product, protecting
beneficiary data privacy or a federal
healthcare program beneficiary from
harm, and taking action to remove
unapproved, misbranded, or adulterated
human or animal products from the
market.
Because of this exception, the
procedures in § 1.9 generally will not
impact, for example, the administrative
detention process for foods, drugs,
devices, and tobacco products (21
U.S.C. 334(g), (h)), the detention,
refusal, and where authorized,
destruction of imported products
regulated by FDA (21 U.S.C. 381),
disqualification (21 CFR parts 56, 58,
312, 511, 812), administrative detention,
recall requests, import alerts, or other
public notifications about food, drug,
VerDate Sep<11>2014
18:22 Jan 13, 2021
Jkt 253001
device, or tobacco products, or other
actions related to investigating
adulterated or misbranded products.
These procedures would also not
apply to settlement negotiations
between agencies and regulated parties,
to notices of a prospective legal action,
where a statute specifically precludes
review of agency action, or to litigation
before courts. Examples of situations
where statutes specifically authorize
differently structured proceedings
include, but are not limited to, the
hospital cost report appeals process (42
U.S.C. 1395oo), the individual benefit
claims appeals process (42 U.S.C.
1395ff), and the process for the review
of disallowances of Medicaid
expenditures by the Secretary (42 U.S.C.
1316(e)). In such circumstances, the
process and substantive standards
governing review of claims arising
under a relevant statute or regulation
remain governed by those more specific
procedures. The procedures would also
not apply to any action related to a
criminal investigation or prosecution,
including undercover operations that
may be used in a criminal investigation
or prosecution, or any civil enforcement
action either related to an investigation
by the Department of Justice, or referred
to the Department of Justice.
III. Rulemaking Analyses and Notices
A. Executive Orders 12866 and 13563
Executive Order 12866, ‘‘Regulatory
Planning and Review,’’ and Executive
Order 13563, ‘‘Improving Regulation
and Regulatory Review,’’ direct agencies
to assess all costs and benefits of
available regulatory alternatives and, if
the regulation is necessary, to select
regulatory approaches that maximize
net benefits. The Department does not
believe that this rulemaking is a
significant regulatory action under these
Executive Orders. This rule describes an
update to the Department’s current
processes to ensure that it operates with
transparency and fairness. The
requirements in 45 CFR 1.6 through 1.9
relating to the proper use of guidance
documents and fairness and notice in
enforcement actions generally already
exist in law. The requirements set forth
in Section 6 of Executive Order 13892
and codified at 45 CFR 1.6 may exceed
the requirements imposed by the Due
Process clause of the Constitution and
may impose a burden by delaying the
time until HHS can take actions with
legal consequence. However, this
process will also offer important
procedural safeguards and potentially
reduce economic costs borne by
regulated entities, which will have an
opportunity to respond in writing before
PO 00000
Frm 00061
Fmt 4700
Sfmt 4700
3013
the Department takes an action that has
(potentially costly) legal consequence.
The Department anticipates that the
public, and, in particular, regulated
parties, would benefit from greater
efficiencies and more transparency in
how the Department regulates,
including facilitating smoother
operations within HHS by clearly
defining how guidance can be used.
B. Executive Order 13771
This final rule is neither a regulatory
nor a deregulatory action under
Executive Order 13771, ‘‘Reducing
Regulation and Controlling Regulatory
Costs,’’ 82 FR 9339 (Feb. 3, 2017),
because this rule is estimated to impose
no more than de minimis costs on
regulated entities.
C. Regulatory Flexibility Act
The Department has examined the
economic implications of this rule as
required by the Regulatory Flexibility
Act (RFA), 5 U.S.C. 601 et seq. The RFA
requires an agency to describe the
impact of a rulemaking on small entities
by providing an initial regulatory
flexibility analysis, unless the agency
expects that the rule will not have a
significant impact on a substantial
number of small entities, provides a
factual basis for this determination, and
proposes to certify the statement. 5
U.S.C. 603(a), 605(b). The Department
considers a proposed or final rule to
have a significant impact on a
substantial number of small entities if it
has at least a three percent impact on
revenue on at least five percent of small
entities. The Department anticipates
that this rule will allow small entities to
operate more efficiently, by increasing
the transparency of government
regulation. As a result, the Department
has determined, and the Secretary
certifies, that this final rule would not
have a significant impact on the
operations of a substantial number of
small entities.
D. Executive Order 13132 (Federalism)
Executive Order 13132, ‘‘Federalism,’’
establishes certain requirements that an
agency must meet when it promulgates
a rule that imposes substantial direct
requirement costs on State and local
governments or has Federalism
implications. The Department has
determined that this final rule will not
impose such costs or have any
federalism implications.
E. Paperwork Reduction Act of 1995
In accordance with the Paperwork
Reduction Act of 1995 and its
implementing regulations, 44 U.S.C.
3501–3521; 5 CFR part 1320, the
E:\FR\FM\14JAR1.SGM
14JAR1
3014
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Rules and Regulations
Department has reviewed this rule and
has determined that it imposes no new
collections of information.
List of Subjects in 45 CFR Part 1
Guidance, Government employess.
For the reasons set forth in the
preamble, the Department of Health and
Human Services amends 45 CFR Part I
as set forth below:
PART 1—TRANSPARENCY AND
FAIRNESS IN CIVIL ADMINISTRATIVE
ENFORCEMENT AND ADJUDICATION
1. The authority citation for part 1
continues to read as follows:
■
Authority: 42 U.S.C. 1302, 5 U.S.C. 301,
551 et seq.
2. Section 1.1 is revised to read as
follows:
■
§ 1.1
Scope.
Sections 1.2(a) and 1.3 through 1.5 of
this part shall apply to guidance
documents issued by all components of
the Department, until the Secretary
amends the Food and Drug
Administration’s good guidance
regulations at 21 CFR 10.115 to bring
them into conformance with the
requirements of this part, at which
point, such amended regulations shall
apply to the Food and Drug
Administration, and §§ 1.2(a) and 1.3
through 1.5 shall apply to all divisions
of the Department except the Food and
Drug Administration. Sections 1.2(b)
and 1.6 through 1.9 of this part shall
apply to all components of the
Department.
■ 3. Section 1.2 is amended by
designating the existing text as
paragraph (a) followed by the
alphabetical ordered definitions,
revising newly designated paragraph (a)
introductory text, and adding paragraph
(b).
The revision and addition read as
follows:
khammond on DSKJM1Z7X2PROD with RULES
§ 1.2
Definitions.
(a) The following definitions apply to
all components of the Department until
the Secretary amends the Food and Drug
Administration’s good guidance
regulations at 21 CFR 10.115 to bring
them into conformance with the
requirements of §§ 1.3 through 1.5 of
this part:
*
*
*
*
*
(b) The following definitions apply to
all components of the Department:
Civil enforcement action means an
action with legal consequence taken by
the Department based on an alleged
violation of the law. Such actions
include administrative enforcement
VerDate Sep<11>2014
18:22 Jan 13, 2021
Jkt 253001
proceedings and enforcement
adjudication (which is the
administrative process undertaken by
any component of the Department to
resolve the legal rights and obligations
of specific parties with regard to a
particular enforcement issue pending
before it) but do not include actions
taken in the normal course of the
Department’s regulatory
communications or decision-making, for
example, decisions on product
applications (such as approvals, denials,
or withdrawals of approval), claims
authorizations, citizen petitions, food or
color additive petitions, or public health
notifications.
Legal consequence means the result of
an action that directly or indirectly
affects substantive legal rights or
obligations, including by subjecting a
regulated party to potential liability in
an enforcement action. This includes
agency letters or orders establishing
greater liability for regulated parties in
a subsequent enforcement action, but
excludes communications that have no
immediate regulatory implications for a
person or entity, such as letters (e.g.,
warning letters) or inspectional
observations that serve as an interim
step in the agency’s compliance
communications with a person or entity
or that are intended to encourage
voluntary compliance.
Unfair surprise means a lack of
reasonable certainty or fair warning,
from the perspective of a reasonably
prudent member of regulated industry,
of what a legal standard administered by
an agency requires.
■ 4. Section 1.6 is added to read as
follows:
§ 1.6 Proper Department reliance on
guidance documents.
(a) Overview. A civil enforcement
action must have an appropriate legal
basis. When the Department takes a civil
enforcement action or makes a
determination based on an alleged
violation of law that has legal
consequence for a person or state, it
must allege or establish the violation of
law by applying statutes or regulations.
(b) Limitations on the use of guidance
documents. (1) The Department may not
use guidance documents to impose
binding requirements or prohibitions on
persons outside the executive branch
except as expressly authorized by law or
as expressly incorporated into a
contract.
(2) The Department may not treat
noncompliance with a standard or
practice announced solely in a guidance
document as itself a violation of
applicable statutes or regulations except
as expressly authorized by law.
PO 00000
Frm 00062
Fmt 4700
Sfmt 4700
(3) If the Department uses a guidance
document to explain the legal
applicability of a statute or regulation,
that document can do no more, with
respect to prohibition of conduct, than
articulate the Department’s
understanding of how a statute or
regulation applies to particular
circumstances.
(4) The Department may cite to a
guidance document in a civil
enforcement action only if it has
notified the public of such document in
advance through publication, in the
Department’s guidance repository, as
described in § 1.4.
■ 5. Section 1.7 is added to read as
follows:
§ 1.7 Fairness and notice in civil
enforcement actions and administrative
inspections.
(a) When the Department takes a civil
enforcement action, the Department
may only apply standards or practices
that have been publicly stated in a
manner that would not cause unfair
surprise.
(b) The Department must avoid unfair
surprise when it imposes penalties and
whenever it adjudges past conduct to
have violated the law.
(c) The Department shall only
conduct civil administrative inspections
according to published rules of agency
procedure.
■ 6. Section 1.8 is added to read as
follows:
§ 1.8 Fairness and notice in jurisdictional
determinations.
(a) If the Department relies on a
decision in an agency adjudication,
administrative order, or agency
document to assert a new or expanded
claim of jurisdiction (e.g., a claim to
regulate a new subject matter or a new
basis for liability, or a relinquishment of
a claim of jurisdiction), the Department
must give fair notice by publishing the
initial decision before the conduct over
which jurisdiction is sought occurs. It
must publish the initial decision in full
or by citation, if publicly available, in
the Federal Register or the Department’s
guidance repository described in § 1.4.
A claim of jurisdiction is not ‘‘new or
expanded’’ simply because it involves a
new or novel set of facts so long as it
is based on an established principle of
general applicability.
(b) If the Department intends to rely
on a document arising out of litigation
(other than a publicly published
opinion of an adjudicator), such as a
brief, a consent decree, or a settlement
agreement, to establish jurisdiction in
future civil enforcement actions
E:\FR\FM\14JAR1.SGM
14JAR1
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Rules and Regulations
involving persons who were not parties
to the litigation, the Department must—
(1) Publish that document, either in
full or by citation if publicly available,
in the Federal Register or on the
Department’s guidance repository
described in § 1.4, and
(2) Publish an explanation of the
document’s jurisdictional implications.
(c) Before seeking judicial deference
to the Department’s interpretation of a
document arising out of litigation (other
than a publicly published opinion of an
adjudicator) in order to establish a new
or expanded claim of jurisdiction in a
different case, the Department must—
(1) Publish the document or a notice
of availability in the Federal Register or
on the Department’s guidance repository
described in § 1.4, and
(2) Publish an explanation of the
document’s jurisdictional implications.
■ 7. Section 1.9 is added to read as
follows:
khammond on DSKJM1Z7X2PROD with RULES
§ 1.9 Opportunity to contest agency
determination.
(a) Departmental overview. Except as
provided in paragraph (c) of this
section, prior to the Department taking
any civil enforcement action with
respect to a particular entity that has
legal consequence for that entity,
including by issuing to such a person a
notice of noncompliance, or other
similar notice that has immediate
regulatory consequence, but excluding
communications that have no
immediate regulatory implications for
the entity, such as those that serve as an
interim step in the agency’s compliance
communications with the entity or that
are intended to encourage voluntary
compliance, the Department shall
provide—
(1) Written notice to the affected
entity of the initial legal and factual
determinations underpinning the initial
adverse determination;
(2) An opportunity for the affected
entity to respond in writing and, if
determined appropriate by the
Department, orally; and
(3) A written response from the
Department to the affected entity after
receiving a timely request from the
affected entity under paragraph (a)(2) of
this section.
(b) Timing and content of written
responses. (1) The Department will
select a meaningful amount of time in
which the affected entity must submit a
written response to the Department.
This writing must be submitted within
the time period specified by the
Department, unless the Department
concludes an extension is warranted,
and state the reasons for the entity’s
disagreement with the Department’s
VerDate Sep<11>2014
18:22 Jan 13, 2021
Jkt 253001
proposed action for purposes of
requiring a response in accordance with
paragraph (a)(3) of this section.
(2) The Department’s written response
must respond to the affected entity and
articulate the basis for its final decision.
This written response may be issued
contemporaneous to the Department
taking the action with legal
consequence.
(c) Exceptions. The procedures in
paragraphs (a) and (b) of this section do
not apply where the Department, in its
discretion, determines there is a serious
threat to health, safety, or similar
emergency, or where a statute
specifically authorizes proceeding
without a prior opportunity to be heard.
In such event, HHS would still provide
an affected entity with an opportunity to
be heard and a written response as soon
as practicable. The procedures in
paragraphs (a) and (b) do not apply to
settlement negotiations between
agencies and regulated parties, to
notices of a prospective legal action, to
litigation before courts, or any action
related to a criminal investigation or
prosecution, including undercover
operations that may be used in a
criminal investigation or prosecution, or
any civil enforcement action either
related to an investigation by the
Department of Justice, or referred to the
Department of Justice.
Dated: January 7, 2021.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2021–00592 Filed 1–12–21; 4:15 pm]
BILLING CODE 4150–26–P
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Part 73
[MB Docket No. 20–340; RM–11865; DA 20–
1425; FRS 17287]
Television Broadcasting Services;
Minneapolis, Minnesota.
Federal Communications
Commission.
ACTION: Final rule.
AGENCY:
The Media Bureau, Video
Division (Bureau) has before it a Notice
of Proposed Rulemaking issued in
response to a petition for rulemaking
filed by Multimedia Holdings
Corporation (Multimedia), licensee of
KARE, channel 11, Minneapolis,
Minnesota, requesting the substitution
of channel 31 for channel 11 at
Minneapolis in the DTV Table of
Allotments. The Bureau had instituted a
SUMMARY:
PO 00000
Frm 00063
Fmt 4700
Sfmt 4700
3015
freeze on the acceptance of rulemaking
petitions by full power television
stations requesting channel
substitutions in May 2011 and waived
the freeze to consider Multimedia’s
proposal to substitute channel 31 at
Minneapolis. TEGNA, Inc., filed
comments in support of the petition
reaffirming its commitment to applying
for channel 31. The Bureau believes the
public interest would be served by the
substitution and will permit the station
to better serve its viewers, who have
experienced reception problems with
VHF channel 11.
DATES:
Effective January 14, 2021.
FOR FURTHER INFORMATION CONTACT:
Joyce Bernstein, Media Bureau, at
Joyce.Bernstein@fcc.gov.
This is a
synopsis of the Commission’s Report
and Order, MB Docket No. 20–340; RM–
11865; DA 20–1425, adopted December
2, 2020, and released December 2, 2020.
The full text of this document is
available for download at https://
www.fcc.gov/edocs. To request materials
in accessible formats for people with
disabilities (braille, large print,
electronic files, audio format), send an
email to fcc504@fcc.gov or call the
Consumer & Governmental Affairs
Bureau at 202–418–0530 (voice), 202–
418–0432 (tty).
This document does not contain
information collection requirements
subject to the Paperwork Reduction Act
of 1995, Public Law 104–13. In addition,
therefore, it does not contain any
proposed information collection burden
‘‘for small business concerns with fewer
than 25 employees,’’ pursuant to the
Small Business Paperwork Relief Act of
2002, Public Law 107–198, see 44 U.S.C.
3506(c)(4). Provisions of the Regulatory
Flexibility Act of 1980, 5 U.S.C. 601–
612, do not apply to this proceeding.
The Commission will send a copy of
this Report and Order in a report to be
sent to Congress and the Government
Accountability Office pursuant to the
Congressional review Act, see 5 U.S.C.
801(a)(1)(A).
SUPPLEMENTARY INFORMATION:
List of Subjects in 47 CFR Part 73
Television.
Federal Communications Commission.
Thomas Horan,
Chief of Staff, Media Bureau.
Final Rule
For the reasons discussed in the
preamble, the Federal Communications
Commission amends 47 CFR part 73 as
follows:
E:\FR\FM\14JAR1.SGM
14JAR1
Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Rules and Regulations]
[Pages 3010-3015]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00592]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
45 CFR Part 1
[HHS-OS-2021-0001]
RIN 0991-AC18
Department of Health and Human Services Transparency and Fairness
in Civil Administrative Enforcement Actions
AGENCY: Office of the Secretary, Department of Health and Human
Services.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services is issuing
regulations promoting transparency and fairness in civil enforcement
actions. These regulations will help to ensure that regulated parties
receive fair notice of laws and regulations they are subject to, and
have an opportunity to contest an agency determination prior to the
agency taking an action that has a legal consequence.
DATES: Effective January 12, 2021.
FOR FURTHER INFORMATION CONTACT: Brenna Jenny, Department of Health and
Human Services, 200 Independence Avenue SW, Room 713F, Washington, DC
20201. Email: [email protected]. Telephone: (202) 690-7741.
I. Statutory and Regulatory Background
The primary legal authority supporting this rulemaking is 5 U.S.C.
301. That provision provides that the ``head of an Executive department
or military department may prescribe regulations for the government of
his department, the conduct of its employees, the distribution and
performance of its business, and the custody, use, and preservation of
its records, papers, and property.'' This statute authorizes an
``agency to regulate its own affairs,'' and issue rules, such as this
one, that are ``rules of agency organization[,] procedure or
practice.'' Chrysler Corp. v. Brown, 441 U.S. 281, 309-10 (1979).
Similarly, 42 U.S.C. 1302 provides that the Secretary ``shall make and
publish such rules and regulations, not inconsistent with this chapter,
as may be necessary to the efficient administration of the functions
with which [he] is charged'' under Chapter 7 of the Social Security
Act. Chapter 7 contains, among other things, statutory provisions
governing Medicare, Medicaid, and the Health Insurance Portability and
Accountability Act (HIPAA).
The Administrative Procedure Act (``APA''), 5 U.S.C. 551 et seq.,
specifies the process by which such regulations are promulgated.
Department heads generally must prescribe regulations through notice-
and-comment rulemaking, but there is an exception for ``rules of agency
organization, procedure, or practice.'' The requirements for notice and
comment prior to finalization also do not apply to regulations that
involve ``a matter relating to agency management or personnel.'' 5
U.S.C. 553(a)(2).
Because this final rule only specifies procedures that agency
personnel must follow or that will govern civil enforcement actions, it
is exempt from the requirement for notice and comment prior to
finalization. In determining whether notice-and-comment rulemaking is
required, the ``critical feature is that [the rule] covers agency
actions that do not themselves alter the rights or interests of the
parties, although it may alter the manner in which the parties present
themselves or their viewpoints to the agency.'' Nat'l Sec. Counselors
v. CIA, 931 F. Supp. 2d 77, 106-07 (D.D.C. 2013) (quoting Batterton v.
Marshall, 648 F.2d 694, 707 (D.C. Cir. 1980)). This rule is exempt from
notice and comment because it does not ``put[ ] a stamp of approval or
disapproval on a given type of behavior.'' Am. Hosp. Assoc. v. Bowen,
834 F.2d 1037, 1047 (D.C. Cir. 1987). What had been a regulatory
violation prior to finalization of this rule still is; the Department
of Health and Human Services (``HHS'' or ``the Department'') is only
modifying the procedures governing civil enforcement actions and the
Department's civil enforcement action practices. To be sure, these
procedural modifications, like most rules of agency procedure or
personnel, might have some impact on the public. But agency rules that
impose ``derivative,'' ``incidental,'' or ``mechanical'' burdens upon
regulated individuals are considered procedural, rather than
substantive, and are therefore exempt from the notice-and-comment
requirement. Id. at 1051. Moreover, to the extent this rule has effects
on the public, it only provides additional protections to the public,
rather than depriving the public of any rights or interests it
previously had.
The APA requires that ``administrative policies affecting
individual rights and obligations be promulgated pursuant to certain
stated procedures so as to avoid the inherently arbitrary nature of
unpublished ad hoc determinations.'' Morton v. Ruiz, 415 U.S. 199, 232
(1974). The Freedom of Information Act amended the APA to advance this
goal, and generally requires that agencies publish in the Federal
Register their substantive rules of general applicability, statements
of general policy, and interpretations of law that are generally
applicable. 5 U.S.C. 552(a)(1)(D). Unless a party has actual and timely
notice of the terms of a rule or policy, the Freedom of Information Act
generally provides that a party may not be adversely affected by a rule
or policy required to be published in the Federal Register that is not
so published. 5 U.S.C. 552(a)(1)(flush language). This rule of agency
procedure ensures that HHS actions comport with these requirements.
II. Summary of Transparency and Fairness Regulations
To provide regulated parties with greater transparency and fairness
in administrative actions, and consistent with the requirements of
Executive Order 13892 of October 9, 2019, ``Promoting the Rule of Law
Through Transparency and Fairness in Civil Administrative Enforcement
and Adjudication,'' 84 FR 55239 (Oct. 15, 2019), HHS is setting forth
policies that promote transparency and fairness in civil enforcement
actions that will apply to all divisions of HHS. The requirements in
this rule amend 45 CFR part 1.
[[Page 3011]]
This rule is one component of the Department's broader regulatory
reform initiative. The rule is designed to ensure accountability,
fairness of how the Department uses guidance, proper use of guidance
documents, and opportunities for third parties to be heard, and to
safeguard the important principles underlying the United States
administrative law system.
A. Scope (45 CFR 1.1)
The requirements established pursuant to this rule in Sec. Sec.
1.2(b) and 1.6 through 1.9 apply to civil enforcement actions by any
component of the Department. Sections 1.3 through 1.5 (as well as the
definitions in Sec. 1.2 that were added through the Good Guidance
Practices final rule at 85 FR 78770 (Dec. 7, 2020), and that we will
recodify in this rule at Sec. 1.2(a)) will continue to apply to all
guidance documents until FDA amends its good guidance practices
regulation to be consistent with the HHS Good Guidance Practices rule,
at which point Sec. Sec. 1.2(a) and 1.3 through 1.5 shall apply to all
divisions of HHS except FDA.
Nothing in this rule shall apply:
To any action that pertains to foreign or military
affairs, or to a national security or homeland security function of the
United States (other than procurement actions and actions involving the
import or export of nondefense articles and services);
To any action related to a criminal investigation or
prosecution, including undercover operations, or any civil enforcement
action or related investigation by the Department of Justice, including
any action related to a civil investigative demand under 18 U.S.C.
1968;
To any action related to detention, seizure, or
destruction of counterfeit goods, pirated goods, or other goods that
infringe intellectual property rights;
To any investigation of misconduct by an agency employee
or any disciplinary, corrective, or employment action taken against an
agency employee; or
In any other circumstance or proceeding to which
application of this order, or any part of this order, would, in the
judgment of the Secretary of HHS, undermine the national security.
B. Definitions (45 CFR 1.2)
The definitions section at 45 CFR 1.2 is amended to include the
following definitions at paragraph (b).
Civil Enforcement Action
HHS defines ``civil enforcement action'' to mean an action with
legal consequence taken by the Department based on an alleged violation
of the law. Such actions include administrative enforcement proceedings
and enforcement adjudication (which is the administrative process
undertaken by any component of the Department to resolve the legal
rights and obligations of specific parties with regard to a particular
enforcement issue pending before it) but do not include actions taken
in the normal course of the Department's regulatory communications or
decision-making, for example, decisions on product applications (such
as approvals or denials/withdrawals of approval), claims
authorizations, responses to citizen petitions, food or color additive
petitions, or public health notifications.
Legal Consequence
HHS defines ``legal consequence'' as the result of an action that
directly or indirectly affects substantive legal rights or obligations
including by subjecting a regulated party to potential liability in an
enforcement action. The meaning of this term is informed by the Supreme
Court's discussion in U.S. Army Corps of Engineers v. Hawkes Co., 136
S. Ct. 1807, 1813-16 (2016), and includes, for example, agency letters
or orders establishing or increasing the probability of liability for
regulated parties in a subsequent enforcement action, Ipsen
Biopharmaceuticals, Inc. v. Azar, 943 F.3d 953, 956 (D.C. Cir. 2019);
Rhea Lana, Inc. v. Dep't of Labor, 824 F.3d 1023, 1030 (D.C. Cir.
2016). It does not include a warning letter or other communication,
such as one describing inspectional observations, that pursuant to
agency policy is intended to provide notice to a regulated party and
elicit voluntary compliance. Such warning letters and inspectional
observations have no immediate regulatory implications for the entity,
are an interim step in the agency's compliance communications with an
entity, and are not final agency action that has legal consequences for
a party. See Orton Motor, Inc. v. HHS, 884 F.3d 1205, 1215 (D.C. Cir.
2018); Holistic Candlers & Consumers Ass'n v. FDA, 664 F.3d 940 (D.C.
Cir. 2012); see also Hi-Tech Pharm., Inc. v. Hahn, Civ. No. 19-
1268(RBW), 2020 WL 3498588, *5 (D.D.C. June 29, 2020); Lystn, LLC v.
FDA, No. 19-cv-1943-PAB-KLM, 2020 WL 248962, *5 (D. Colo. Jan. 16,
2020); Cody Labs., Inc. v. Sebelius, No. 10-CV-00147-ABJ, 2010 WL
3119279, *11 (D. Wyo. July 26, 2010), aff'd, 446 F. App'x 964, 969
(10th Cir. 2011); Gomperts v. Azar, No. 1:19-cv-00345-DCN, 2020 WL
3963864, *4-5 (D. Idaho July 13, 2020).
Unfair Surprise
HHS defines ``unfair surprise'' to mean a lack of reasonable
certainty or fair warning, from the perspective of a reasonably prudent
member of regulated industry, of what a legal standard administered by
an agency requires, or the initiation of litigation by HHS following
``a very lengthy period of conspicuous inaction,'' in other words
deliberate inaction, suggesting the agency previously had a different
interpretation. Christopher v. SmithKline Beecham Corp., 567 U.S. 142,
156 (2012). However, an agency does not create unfair surprise when it
proceeds with a new interpretation that it established in notice-and-
comment rulemaking. See Martin v. Occupational Safety & Health Review
Comm'n, 499 U.S. 144, 158 (1991) (identifying ``adequacy of notice to
regulated parties'' as one factor relevant to the reasonableness of the
agency's interpretation).
The definitions currently at 45 CFR 1.2 will be moved into a new
paragraph (a). All definitions at paragraph (a) apply to all components
of HHS until FDA amends its good guidance practices regulation, at
which point the definitions at 45 CFR 1.2(a) shall apply to all
divisions of HHS except FDA. The definitions at Sec. 1.2(b) will apply
to all components of the Department, including FDA.
C. Proper Department Reliance on Guidance Documents (45 CFR 1.6)
This rule reiterates the application of certain existing legal
principles to HHS's use of guidance documents: When the Department
takes a civil enforcement action or otherwise makes a determination
based on an alleged violation of law that has legal consequence for a
person or state, it must allege or establish the violation of law by
applying statutes or regulations. HHS may not use guidance documents to
impose binding requirements or prohibitions on persons outside of the
executive branch except as authorized by law or expressly incorporated
into a contract. Noncompliance with a standard or practice that is not
in a statute or regulation and announced solely in a guidance document
may not be treated as itself a violation of applicable statutes or
regulations, unless expressly authorized by statute.
This rule also explains the appropriate circumstances when the
Department may use a guidance document in civil enforcement actions.
The Department may use a guidance document to explain the legal
applicability of a statute or regulation
[[Page 3012]]
with regard to prohibition of conduct, but when it does so, HHS may
only use the guidance document to articulate the Department's
understanding of how a statute or regulation applies to particular
circumstances. Except when referring to a guidance document for
historical facts, the Department may reference a guidance document in a
civil enforcement action only if it has notified the public of such
document to convey that understanding in advance. The Department must
notify the public in advance of a guidance document through publication
in the Department's guidance repository (as described in Sec. 1.4 and
available at hhs.gov/guidance).
D. Fairness and Notice in Civil Enforcement Actions and Administrative
Inspections (45 CFR 1.7)
This rule would require the Department to only apply standards or
practices that have been publicly stated in a manner that would not
cause unfair surprise when HHS takes a civil enforcement action or
otherwise makes a determination based on an alleged violation of law
that has legal consequence for a person or state, unless a statutory
exception applies. See, e.g., 42 U.S.C. 1395hh(e). For purposes of this
regulation, the Department would consider standards or practices to be
publicly stated if available in paper publications or on the internet.
HHS avoids unfair surprise not only when it imposes penalties but
also whenever it adjudges past conduct to have violated the law. For
example, the Department generally cannot retroactively impose liability
on a party for conduct that violates a new agency interpretation. But
see 42 U.S.C. 1395hh(e). The Department also may not alter its
interpretation during an adjudicative proceeding if doing so would
impose new liability on parties who have acted in good faith on the
prior interpretation. SmithKline Beecham, 567 U.S. at 156 & n.15.
Section 7 of Executive Order 13892 requires that each agency that
conducts civil administrative inspections must publish a rule of agency
procedure governing such inspections, if such a rule does not already
exist. The Department is adding a requirement at 45 CFR 1.7 that HHS
shall only conduct civil administrative inspections according to
published rules of agency procedure. While the Administrative Procedure
Act exempts these subsequently issued rules of agency procedure
themselves from notice-and-comment rulemaking, see 5 U.S.C.
553(b)(3)(A), each agency must make the rules governing its civil
administrative inspections, including audits, publicly available and
readily accessible, such as by posting them on a website.
E. Fairness and Notice in Jurisdictional Determinations (45 CFR 1.8)
The requirement for fairness and notice also extends to
jurisdictional determinations. If the Department relies on a decision
previously issued by an agency within the Department in an agency
adjudication (i.e., proceedings before and decided by the agency),
administrative order, or agency document to assert a new or expanded
claim of jurisdiction (e.g., a claim to regulate a new subject matter
or a new basis for liability, or a relinquishment of a claim of
jurisdiction), the Department must give fair notice by publishing the
initial decision in the Federal Register or the Department's guidance
repository. See 45 CFR 1.4. The Department should not rely on the new
claim of jurisdiction to take a civil enforcement action regarding
conduct that occurred before such publication. A claim of jurisdiction
is not ``new or expanded'' simply because it involves a new or novel
set of facts so long as it is based on an established principle of
general applicability.
If the Department intends to rely on a document arising out of
litigation (other than a publicly published opinion of an adjudicator)
such as a brief, a consent decree, or a settlement agreement, to
establish jurisdiction in future civil enforcement actions involving
persons who were not parties to the litigation, the Department must
also publish that document in the Federal Register or on the
Department's guidance repository. Alongside publication of the
document, the Department must also provide an explanation of the
document's jurisdictional implications. Publication of a document
discussed in this paragraph may either be in full or by citation, if
the document is publicly available.
HHS is also proposing that if the Department seeks judicial
deference to its interpretation of a document arising out of litigation
(other than a publicly published opinion of an adjudicator) in order to
establish a new or expanded claim of jurisdiction, HHS must, before
seeking judicial deference, publish the document or a notice of
availability in the Federal Register or on the Department's guidance
repository, along with an explanation of the document's jurisdictional
implications.
F. Opportunity To Contest Agency Determinations (45 CFR 1.9)
Providing regulated parties with the opportunity to be heard,
including through informal oral or written communications, prior to the
Department taking any civil enforcement action that has legal
consequence is critical to ensuring that the Department operates with
transparency and fairness. This rule will require that, before any
component of the Department takes any civil enforcement action with
respect to a particular entity that has legal consequence for that
entity--including by issuing to such a person a notice of noncompliance
or other similar notice that has immediate regulatory consequence or
the immediate effect of subjecting the person to potential liability--
the Department must afford that person an opportunity to be heard,
either orally or in writing, as deemed appropriate at the Department's
election. The rule will require HHS to provide the person with its
proposed legal and factual determinations and then give the person a
reasonable amount of time to respond to those determinations. The
specific timeframe shall be in the discretion of the agency but must be
long enough to provide a meaningful opportunity to be heard. Certain
circumstances may warrant a time period of 30 days, while other
circumstances may warrant a shorter period, such as 15 days or fewer,
particularly where existing agency procedures already offer a shorter
period in which to respond. Unless the Department withdraws the action,
the Department must then respond in writing to the regulated party and
articulate the final basis for the Department's action. This written
response may be issued contemporaneous to the Department taking the
action with legal consequence. We anticipate that generally, existing
HHS procedures will already satisfy these standards, and where they do,
those existing procedures will continue in effect unchanged. This
rulemaking is not intended to preempt existing rules of agency
procedure that are already consistent with this rule. Furthermore,
where the Department takes an action based on a predicate finding that
was reached following notice, an opportunity to be heard, and a written
response, for example, where the Department revokes Medicare enrollment
based on a prior exclusion or felony conviction, these procedural
requirements are considered to have already been satisfied.
[[Page 3013]]
These procedures regarding fair notice and an opportunity to
respond would not apply where the agency, in its discretion, determines
there is a serious threat to health, safety, or similar emergency, or
where a statute specifically authorizes proceedings that are
inconsistent with this section, including proceedings without a prior
opportunity to be heard. Where such a threat arises and a statute does
not specifically authorize proceedings without a prior opportunity to
be heard, HHS would still provide an affected entity with an
opportunity to be heard and a written response as soon as practicable.
In this context, a serious threat means that, as reasonably determined
by the Department, there is a non-negligible likelihood of the threat
materializing.
We anticipate that the exception from Sec. 1.9 for actions taken
in the context of threats to health, safety, or similar emergencies
will apply broadly to public health agencies acting in furtherance of
their missions. Actions will be considered to fall into this exception
regardless of whether there is a showing of actual, imminent risk or
harm, either to persons or animals. The agency has sole discretion to
determine when an action falls into this exception. An agency may
invoke this exception regardless of whether agency action is taken
reactively (e.g., to address an unsafe item currently on the market) or
proactively (e.g., to enforce regulations needed to protect public
health prior to actual exposure by the public to unsafe items). Actions
that fall into this exception include, for example, enforcing age
restrictions or other controls around access to certain regulated
products, enforcing manufacturer recordkeeping or reporting
requirements, enforcing premarket requirements where there is an
absence of or insufficient data concerning the product, protecting
beneficiary data privacy or a federal healthcare program beneficiary
from harm, and taking action to remove unapproved, misbranded, or
adulterated human or animal products from the market.
Because of this exception, the procedures in Sec. 1.9 generally
will not impact, for example, the administrative detention process for
foods, drugs, devices, and tobacco products (21 U.S.C. 334(g), (h)),
the detention, refusal, and where authorized, destruction of imported
products regulated by FDA (21 U.S.C. 381), disqualification (21 CFR
parts 56, 58, 312, 511, 812), administrative detention, recall
requests, import alerts, or other public notifications about food,
drug, device, or tobacco products, or other actions related to
investigating adulterated or misbranded products.
These procedures would also not apply to settlement negotiations
between agencies and regulated parties, to notices of a prospective
legal action, where a statute specifically precludes review of agency
action, or to litigation before courts. Examples of situations where
statutes specifically authorize differently structured proceedings
include, but are not limited to, the hospital cost report appeals
process (42 U.S.C. 1395oo), the individual benefit claims appeals
process (42 U.S.C. 1395ff), and the process for the review of
disallowances of Medicaid expenditures by the Secretary (42 U.S.C.
1316(e)). In such circumstances, the process and substantive standards
governing review of claims arising under a relevant statute or
regulation remain governed by those more specific procedures. The
procedures would also not apply to any action related to a criminal
investigation or prosecution, including undercover operations that may
be used in a criminal investigation or prosecution, or any civil
enforcement action either related to an investigation by the Department
of Justice, or referred to the Department of Justice.
III. Rulemaking Analyses and Notices
A. Executive Orders 12866 and 13563
Executive Order 12866, ``Regulatory Planning and Review,'' and
Executive Order 13563, ``Improving Regulation and Regulatory Review,''
direct agencies to assess all costs and benefits of available
regulatory alternatives and, if the regulation is necessary, to select
regulatory approaches that maximize net benefits. The Department does
not believe that this rulemaking is a significant regulatory action
under these Executive Orders. This rule describes an update to the
Department's current processes to ensure that it operates with
transparency and fairness. The requirements in 45 CFR 1.6 through 1.9
relating to the proper use of guidance documents and fairness and
notice in enforcement actions generally already exist in law. The
requirements set forth in Section 6 of Executive Order 13892 and
codified at 45 CFR 1.6 may exceed the requirements imposed by the Due
Process clause of the Constitution and may impose a burden by delaying
the time until HHS can take actions with legal consequence. However,
this process will also offer important procedural safeguards and
potentially reduce economic costs borne by regulated entities, which
will have an opportunity to respond in writing before the Department
takes an action that has (potentially costly) legal consequence.
The Department anticipates that the public, and, in particular,
regulated parties, would benefit from greater efficiencies and more
transparency in how the Department regulates, including facilitating
smoother operations within HHS by clearly defining how guidance can be
used.
B. Executive Order 13771
This final rule is neither a regulatory nor a deregulatory action
under Executive Order 13771, ``Reducing Regulation and Controlling
Regulatory Costs,'' 82 FR 9339 (Feb. 3, 2017), because this rule is
estimated to impose no more than de minimis costs on regulated
entities.
C. Regulatory Flexibility Act
The Department has examined the economic implications of this rule
as required by the Regulatory Flexibility Act (RFA), 5 U.S.C. 601 et
seq. The RFA requires an agency to describe the impact of a rulemaking
on small entities by providing an initial regulatory flexibility
analysis, unless the agency expects that the rule will not have a
significant impact on a substantial number of small entities, provides
a factual basis for this determination, and proposes to certify the
statement. 5 U.S.C. 603(a), 605(b). The Department considers a proposed
or final rule to have a significant impact on a substantial number of
small entities if it has at least a three percent impact on revenue on
at least five percent of small entities. The Department anticipates
that this rule will allow small entities to operate more efficiently,
by increasing the transparency of government regulation. As a result,
the Department has determined, and the Secretary certifies, that this
final rule would not have a significant impact on the operations of a
substantial number of small entities.
D. Executive Order 13132 (Federalism)
Executive Order 13132, ``Federalism,'' establishes certain
requirements that an agency must meet when it promulgates a rule that
imposes substantial direct requirement costs on State and local
governments or has Federalism implications. The Department has
determined that this final rule will not impose such costs or have any
federalism implications.
E. Paperwork Reduction Act of 1995
In accordance with the Paperwork Reduction Act of 1995 and its
implementing regulations, 44 U.S.C. 3501-3521; 5 CFR part 1320, the
[[Page 3014]]
Department has reviewed this rule and has determined that it imposes no
new collections of information.
List of Subjects in 45 CFR Part 1
Guidance, Government employess.
For the reasons set forth in the preamble, the Department of Health
and Human Services amends 45 CFR Part I as set forth below:
PART 1--TRANSPARENCY AND FAIRNESS IN CIVIL ADMINISTRATIVE
ENFORCEMENT AND ADJUDICATION
0
1. The authority citation for part 1 continues to read as follows:
Authority: 42 U.S.C. 1302, 5 U.S.C. 301, 551 et seq.
0
2. Section 1.1 is revised to read as follows:
Sec. 1.1 Scope.
Sections 1.2(a) and 1.3 through 1.5 of this part shall apply to
guidance documents issued by all components of the Department, until
the Secretary amends the Food and Drug Administration's good guidance
regulations at 21 CFR 10.115 to bring them into conformance with the
requirements of this part, at which point, such amended regulations
shall apply to the Food and Drug Administration, and Sec. Sec. 1.2(a)
and 1.3 through 1.5 shall apply to all divisions of the Department
except the Food and Drug Administration. Sections 1.2(b) and 1.6
through 1.9 of this part shall apply to all components of the
Department.
0
3. Section 1.2 is amended by designating the existing text as paragraph
(a) followed by the alphabetical ordered definitions, revising newly
designated paragraph (a) introductory text, and adding paragraph (b).
The revision and addition read as follows:
Sec. 1.2 Definitions.
(a) The following definitions apply to all components of the
Department until the Secretary amends the Food and Drug
Administration's good guidance regulations at 21 CFR 10.115 to bring
them into conformance with the requirements of Sec. Sec. 1.3 through
1.5 of this part:
* * * * *
(b) The following definitions apply to all components of the
Department:
Civil enforcement action means an action with legal consequence
taken by the Department based on an alleged violation of the law. Such
actions include administrative enforcement proceedings and enforcement
adjudication (which is the administrative process undertaken by any
component of the Department to resolve the legal rights and obligations
of specific parties with regard to a particular enforcement issue
pending before it) but do not include actions taken in the normal
course of the Department's regulatory communications or decision-
making, for example, decisions on product applications (such as
approvals, denials, or withdrawals of approval), claims authorizations,
citizen petitions, food or color additive petitions, or public health
notifications.
Legal consequence means the result of an action that directly or
indirectly affects substantive legal rights or obligations, including
by subjecting a regulated party to potential liability in an
enforcement action. This includes agency letters or orders establishing
greater liability for regulated parties in a subsequent enforcement
action, but excludes communications that have no immediate regulatory
implications for a person or entity, such as letters (e.g., warning
letters) or inspectional observations that serve as an interim step in
the agency's compliance communications with a person or entity or that
are intended to encourage voluntary compliance.
Unfair surprise means a lack of reasonable certainty or fair
warning, from the perspective of a reasonably prudent member of
regulated industry, of what a legal standard administered by an agency
requires.
0
4. Section 1.6 is added to read as follows:
Sec. 1.6 Proper Department reliance on guidance documents.
(a) Overview. A civil enforcement action must have an appropriate
legal basis. When the Department takes a civil enforcement action or
makes a determination based on an alleged violation of law that has
legal consequence for a person or state, it must allege or establish
the violation of law by applying statutes or regulations.
(b) Limitations on the use of guidance documents. (1) The
Department may not use guidance documents to impose binding
requirements or prohibitions on persons outside the executive branch
except as expressly authorized by law or as expressly incorporated into
a contract.
(2) The Department may not treat noncompliance with a standard or
practice announced solely in a guidance document as itself a violation
of applicable statutes or regulations except as expressly authorized by
law.
(3) If the Department uses a guidance document to explain the legal
applicability of a statute or regulation, that document can do no more,
with respect to prohibition of conduct, than articulate the
Department's understanding of how a statute or regulation applies to
particular circumstances.
(4) The Department may cite to a guidance document in a civil
enforcement action only if it has notified the public of such document
in advance through publication, in the Department's guidance
repository, as described in Sec. 1.4.
0
5. Section 1.7 is added to read as follows:
Sec. 1.7 Fairness and notice in civil enforcement actions and
administrative inspections.
(a) When the Department takes a civil enforcement action, the
Department may only apply standards or practices that have been
publicly stated in a manner that would not cause unfair surprise.
(b) The Department must avoid unfair surprise when it imposes
penalties and whenever it adjudges past conduct to have violated the
law.
(c) The Department shall only conduct civil administrative
inspections according to published rules of agency procedure.
0
6. Section 1.8 is added to read as follows:
Sec. 1.8 Fairness and notice in jurisdictional determinations.
(a) If the Department relies on a decision in an agency
adjudication, administrative order, or agency document to assert a new
or expanded claim of jurisdiction (e.g., a claim to regulate a new
subject matter or a new basis for liability, or a relinquishment of a
claim of jurisdiction), the Department must give fair notice by
publishing the initial decision before the conduct over which
jurisdiction is sought occurs. It must publish the initial decision in
full or by citation, if publicly available, in the Federal Register or
the Department's guidance repository described in Sec. 1.4. A claim of
jurisdiction is not ``new or expanded'' simply because it involves a
new or novel set of facts so long as it is based on an established
principle of general applicability.
(b) If the Department intends to rely on a document arising out of
litigation (other than a publicly published opinion of an adjudicator),
such as a brief, a consent decree, or a settlement agreement, to
establish jurisdiction in future civil enforcement actions
[[Page 3015]]
involving persons who were not parties to the litigation, the
Department must--
(1) Publish that document, either in full or by citation if
publicly available, in the Federal Register or on the Department's
guidance repository described in Sec. 1.4, and
(2) Publish an explanation of the document's jurisdictional
implications.
(c) Before seeking judicial deference to the Department's
interpretation of a document arising out of litigation (other than a
publicly published opinion of an adjudicator) in order to establish a
new or expanded claim of jurisdiction in a different case, the
Department must--
(1) Publish the document or a notice of availability in the Federal
Register or on the Department's guidance repository described in Sec.
1.4, and
(2) Publish an explanation of the document's jurisdictional
implications.
0
7. Section 1.9 is added to read as follows:
Sec. 1.9 Opportunity to contest agency determination.
(a) Departmental overview. Except as provided in paragraph (c) of
this section, prior to the Department taking any civil enforcement
action with respect to a particular entity that has legal consequence
for that entity, including by issuing to such a person a notice of
noncompliance, or other similar notice that has immediate regulatory
consequence, but excluding communications that have no immediate
regulatory implications for the entity, such as those that serve as an
interim step in the agency's compliance communications with the entity
or that are intended to encourage voluntary compliance, the Department
shall provide--
(1) Written notice to the affected entity of the initial legal and
factual determinations underpinning the initial adverse determination;
(2) An opportunity for the affected entity to respond in writing
and, if determined appropriate by the Department, orally; and
(3) A written response from the Department to the affected entity
after receiving a timely request from the affected entity under
paragraph (a)(2) of this section.
(b) Timing and content of written responses. (1) The Department
will select a meaningful amount of time in which the affected entity
must submit a written response to the Department. This writing must be
submitted within the time period specified by the Department, unless
the Department concludes an extension is warranted, and state the
reasons for the entity's disagreement with the Department's proposed
action for purposes of requiring a response in accordance with
paragraph (a)(3) of this section.
(2) The Department's written response must respond to the affected
entity and articulate the basis for its final decision. This written
response may be issued contemporaneous to the Department taking the
action with legal consequence.
(c) Exceptions. The procedures in paragraphs (a) and (b) of this
section do not apply where the Department, in its discretion,
determines there is a serious threat to health, safety, or similar
emergency, or where a statute specifically authorizes proceeding
without a prior opportunity to be heard. In such event, HHS would still
provide an affected entity with an opportunity to be heard and a
written response as soon as practicable. The procedures in paragraphs
(a) and (b) do not apply to settlement negotiations between agencies
and regulated parties, to notices of a prospective legal action, to
litigation before courts, or any action related to a criminal
investigation or prosecution, including undercover operations that may
be used in a criminal investigation or prosecution, or any civil
enforcement action either related to an investigation by the Department
of Justice, or referred to the Department of Justice.
Dated: January 7, 2021.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2021-00592 Filed 1-12-21; 4:15 pm]
BILLING CODE 4150-26-P